Aarhus University Seal / Aarhus Universitets segl

Peter Vedsted

Cancer patients' experiences with urgent referrals to cancer patient pathways

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Cancer patients' experiences with urgent referrals to cancer patient pathways. / Thønnings Sandager, Mette; Jensen, Henry; Lipczak, Henriette; Sperling, Cecilie Dyg; Vedsted, Peter.

I: European Journal of Cancer Care, Bind 28, Nr. 1, e12927, 01.2019, s. 1-11.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Thønnings Sandager, M, Jensen, H, Lipczak, H, Sperling, CD & Vedsted, P 2019, 'Cancer patients' experiences with urgent referrals to cancer patient pathways', European Journal of Cancer Care, bind 28, nr. 1, e12927, s. 1-11. https://doi.org/10.1111/ecc.12927

APA

Thønnings Sandager, M., Jensen, H., Lipczak, H., Sperling, C. D., & Vedsted, P. (2019). Cancer patients' experiences with urgent referrals to cancer patient pathways. European Journal of Cancer Care, 28(1), 1-11. [e12927]. https://doi.org/10.1111/ecc.12927

CBE

Thønnings Sandager M, Jensen H, Lipczak H, Sperling CD, Vedsted P. 2019. Cancer patients' experiences with urgent referrals to cancer patient pathways. European Journal of Cancer Care. 28(1):1-11. https://doi.org/10.1111/ecc.12927

MLA

Thønnings Sandager, Mette o.a.. "Cancer patients' experiences with urgent referrals to cancer patient pathways". European Journal of Cancer Care. 2019, 28(1). 1-11. https://doi.org/10.1111/ecc.12927

Vancouver

Thønnings Sandager M, Jensen H, Lipczak H, Sperling CD, Vedsted P. Cancer patients' experiences with urgent referrals to cancer patient pathways. European Journal of Cancer Care. 2019 jan;28(1):1-11. e12927. https://doi.org/10.1111/ecc.12927

Author

Thønnings Sandager, Mette ; Jensen, Henry ; Lipczak, Henriette ; Sperling, Cecilie Dyg ; Vedsted, Peter. / Cancer patients' experiences with urgent referrals to cancer patient pathways. I: European Journal of Cancer Care. 2019 ; Bind 28, Nr. 1. s. 1-11.

Bibtex

@article{36df23fa7ac4441cb99b5a57407346f1,
title = "Cancer patients' experiences with urgent referrals to cancer patient pathways",
abstract = "Objective: We aimed to explore whether cancer patients urgently referred to a cancer patient pathway (CPP) (CPP referred) by a general practitioner report experiences of pre-diagnosis cancer care differently than patients not referred to a CPP (non-CPP referred). Methods: Data were collected from cross-sectional questionnaire surveys among cancer patients and their GPs and linked to National registries. Poisson regression was used to generate adjusted prevalence ratios (PR) to compare reported experiences. Results: The study included 2,256 individuals. CPP referred patients reported more positive overall experiences of the pre-diagnosis phase (p < 0.001). Overall, CPP referred patients were 21% more likely than non-CPP referred patients to report a positive experience after adjustment for case-mix, comorbidity, disposable household income and educational level (PR = 1.21 [95% CI: 1.11–1.30]). The difference decreased to 14% when adjusted for Quality Deviations (PR = 1.14 [95% CI: 1.06–1.23]) and to 11% when adjusted for diagnostic interval (PR = 1.11 [95% CI: 1.02–1.20]). Conclusion: Our findings suggest that CPP referred cancer patients have better experiences of pre-diagnosis cancer care compared to non-CPP referred patients. A substantial part of the difference could be attributed to shorter diagnostic intervals and/or the absence of quality deviations among CPP patients, which reveals the potential for generally improving cancer patients{\textquoteright} experiences by seamless and optimised diagnostic pathways.",
keywords = "cancer, cancer patient pathways, general practice, neoplasm, patient experiences, MORTALITY, IMPLEMENTATION, GENERAL-PRACTICE, PATTERNS, TIME, QUALITY DEVIATIONS, CARE, DANISH CANCER, SATISFACTION, DIAGNOSTIC INTERVALS",
author = "{Th{\o}nnings Sandager}, Mette and Henry Jensen and Henriette Lipczak and Sperling, {Cecilie Dyg} and Peter Vedsted",
note = "{\textcopyright} 2018 John Wiley & Sons Ltd.",
year = "2019",
month = jan,
doi = "10.1111/ecc.12927",
language = "English",
volume = "28",
pages = "1--11",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell Publishing Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Cancer patients' experiences with urgent referrals to cancer patient pathways

AU - Thønnings Sandager, Mette

AU - Jensen, Henry

AU - Lipczak, Henriette

AU - Sperling, Cecilie Dyg

AU - Vedsted, Peter

N1 - © 2018 John Wiley & Sons Ltd.

PY - 2019/1

Y1 - 2019/1

N2 - Objective: We aimed to explore whether cancer patients urgently referred to a cancer patient pathway (CPP) (CPP referred) by a general practitioner report experiences of pre-diagnosis cancer care differently than patients not referred to a CPP (non-CPP referred). Methods: Data were collected from cross-sectional questionnaire surveys among cancer patients and their GPs and linked to National registries. Poisson regression was used to generate adjusted prevalence ratios (PR) to compare reported experiences. Results: The study included 2,256 individuals. CPP referred patients reported more positive overall experiences of the pre-diagnosis phase (p < 0.001). Overall, CPP referred patients were 21% more likely than non-CPP referred patients to report a positive experience after adjustment for case-mix, comorbidity, disposable household income and educational level (PR = 1.21 [95% CI: 1.11–1.30]). The difference decreased to 14% when adjusted for Quality Deviations (PR = 1.14 [95% CI: 1.06–1.23]) and to 11% when adjusted for diagnostic interval (PR = 1.11 [95% CI: 1.02–1.20]). Conclusion: Our findings suggest that CPP referred cancer patients have better experiences of pre-diagnosis cancer care compared to non-CPP referred patients. A substantial part of the difference could be attributed to shorter diagnostic intervals and/or the absence of quality deviations among CPP patients, which reveals the potential for generally improving cancer patients’ experiences by seamless and optimised diagnostic pathways.

AB - Objective: We aimed to explore whether cancer patients urgently referred to a cancer patient pathway (CPP) (CPP referred) by a general practitioner report experiences of pre-diagnosis cancer care differently than patients not referred to a CPP (non-CPP referred). Methods: Data were collected from cross-sectional questionnaire surveys among cancer patients and their GPs and linked to National registries. Poisson regression was used to generate adjusted prevalence ratios (PR) to compare reported experiences. Results: The study included 2,256 individuals. CPP referred patients reported more positive overall experiences of the pre-diagnosis phase (p < 0.001). Overall, CPP referred patients were 21% more likely than non-CPP referred patients to report a positive experience after adjustment for case-mix, comorbidity, disposable household income and educational level (PR = 1.21 [95% CI: 1.11–1.30]). The difference decreased to 14% when adjusted for Quality Deviations (PR = 1.14 [95% CI: 1.06–1.23]) and to 11% when adjusted for diagnostic interval (PR = 1.11 [95% CI: 1.02–1.20]). Conclusion: Our findings suggest that CPP referred cancer patients have better experiences of pre-diagnosis cancer care compared to non-CPP referred patients. A substantial part of the difference could be attributed to shorter diagnostic intervals and/or the absence of quality deviations among CPP patients, which reveals the potential for generally improving cancer patients’ experiences by seamless and optimised diagnostic pathways.

KW - cancer

KW - cancer patient pathways

KW - general practice

KW - neoplasm

KW - patient experiences

KW - MORTALITY

KW - IMPLEMENTATION

KW - GENERAL-PRACTICE

KW - PATTERNS

KW - TIME

KW - QUALITY DEVIATIONS

KW - CARE

KW - DANISH CANCER

KW - SATISFACTION

KW - DIAGNOSTIC INTERVALS

U2 - 10.1111/ecc.12927

DO - 10.1111/ecc.12927

M3 - Journal article

C2 - 30303244

VL - 28

SP - 1

EP - 11

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 1

M1 - e12927

ER -